Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Global discovery, development and commercialization of proprietary therapeutics4.24B100.00%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States4B93.75%
Europe260.4M6.10%
Other countries6.2M0.15%